The growing challenge of obesity and cancer: an inflammatory issue
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
The prevalence of obesity, an established risk factor for many cancers, has risen steadily for the past several decades in the United States and in many parts of the world. This review synthesizes the evidence on key biological mechanisms underlying the obesity–cancer link, with particular emphasis on the impact of energy balance modulation, such as diet‐induced obesity and calorie restriction, on growth factor signaling pathways and inflammatory processes. Particular attention is placed on the proinflammatory environment associated with the obese state, specifically highlighting the involvement of obesity‐associated hormones/growth factors in crosstalk between macrophages, adipocytes, and epithelial cells in many cancers. Understanding the contribution of obesity to growth factor signaling and chronic inflammation provides mechanistic targets for disrupting the obesity–cancer link.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland
Subbaramaiah, K., Howe, L. R., Bhardwaj, P., Du, B., Gravaghi, C., Yantiss, R. K., Zhou, X. K., Blaho, V. A., Hla, T., Yang, P., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0381 · Cited by 363
RetractedCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Prevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002
Hedley, A. A. (2004) · JAMA · doi:10.1001/jama.291.23.2847 · Cited by 4,460
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
Lord, G. M., Matarese, G., Howard, J. K., Baker, R. J., Bloom, S. R., & Lechler, R. I. (1998) · Nature · doi:10.1038/29795 · Cited by 2,160
Weight gain as a risk factor for clinical diabetes mellitus in women
Colditz, G. A., Willett, W. C., Rotnitzky, A., & Manson, J. E. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-7-199504010-00001 · Cited by 2,064
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Visceral fat adipokine secretion is associated with systemic inflammation in obese humans
Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E., & Klein, S. (2007) · Diabetes · doi:10.2337/db06-1656 · Cited by 1,417
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,386
NF-kB in development and progression of human cancer
Dolcet, X., Llobet, D., Pallares, J., & Matias-Guiu, X. (2005) · Virchows Archiv · doi:10.1007/s00428-005-1264-9 · Cited by 1,169
The insulin-like growth factor system and cancer
LeRoith, D., & Roberts, C. T. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00159-9 · Cited by 1,124
Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,119
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Leptin: a review of its peripheral actions and interactions
Margetic, S., Gazzola, C., Pegg, G., & Hill, R. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802142 · Cited by 1,005
TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENT
Tlsty, T. D., & Coussens, L. M. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100224 · Cited by 987
Calle, E. E., & Thun, M. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207751 · Cited by 769
The biology of leptin: a review.
Houseknecht, K. L., Baile, C. A., Matteri, R. L., & Spurlock, M. E. (1998) · Journal of Animal Science · doi:10.2527/1998.7651405x · Cited by 744
Clustering of metabolic factors and coronary heart disease
Wilson, P. W. F., Kannel, W. B., Silbershatz, H., & D'Agostino, R. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1104 · Cited by 712
The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance
Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00607.x · Cited by 651
Prognostic value of intratumoral natural killer cells in gastric carcinoma
Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Che, X., Iwashige, H., Aridome, K., Hokita, S., & Aikou, T. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000201)88:3<577::aid-cncr13>3.0.co;2-v · Cited by 586
Havel, P. J. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00008 · Cited by 575
Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
Wolk, A., Mantzoros, C. S., Andersson, S.-O., Bergstrom, R., Signorello, L. B., Lagiou, P., Adami, H.-O., & Trichopoulos, D. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.911 · Cited by 575
Preadipocyte Conversion to Macrophage
Charrière, G., Cousin, B., Arnaud, E., André, M., Bacou, F., Pénicaud, L., & Casteilla, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210811200 · Cited by 520
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
Vona-Davis, L., & Rose, D. P. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-06-0068 · Cited by 496
Sulindac Inhibits Activation of the NF-κB Pathway
Yamamoto, Y., Yin, M.-J., Lin, K.-M., & Gaynor, R. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27307 · Cited by 494
Low Plasma Adiponectin Levels and Risk of Colorectal Cancer in Men: A Prospective Study
Wei, E. K., Giovannucci, E., Fuchs, C. S., Willett, W. C., & Mantzoros, C. S. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji376 · Cited by 492
Weisberg, S. P., Leibel, R., & Tortoriello, D. V. (2008) · Endocrinology · doi:10.1210/en.2008-0262 · Cited by 480
Mitsiades, C. S., Mitsiades, N., Poulaki, V., Schlossman, R., Akiyama, M., Chauhan, D., Hideshima, T., Treon, S. P., Munshi, N. C., Richardson, P. G., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205664 · Cited by 464
Shishodia, S., Amin, H. M., Lai, R., & Aggarwal, B. B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.043 · Cited by 459
Leek, R. D., Landers, R. J., Harris, A. L., & Lewis, C. E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690158 · Cited by 451
Ma, M. H., Yang, H. H., Parker, K., Manyak, S. J., Friedman, J. M., Altamirano, C. V., Wu, Z.-Q., Borad, M. J., Frantzen, M., Roussos, E., et al. (2003) · PubMed · Cited by 414
Obesity and cancer: Pathophysiological and biological mechanisms
Renehan, A. G., Roberts, D. L., & Dive, C. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801954303 · Cited by 402
Nutrition, hormones, and breast cancer: Is insulin the missing link?
Kaaks, R. (1996) · Cancer Causes and Control · doi:10.1007/bf00051703 · Cited by 360
Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence
Barb, D., Williams, C. J., Neuwirth, A. K., & Mantzoros, C. S. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.858s · Cited by 338
Frystyk, J. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.06.001 · Cited by 338
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Pisani, P. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801954451 · Cited by 329
Obesity and colon cancer: Does leptin provide a link?
Stattin, P., Lukanova, A., Biessy, C., Söderberg, S., Palmqvist, R., Kaaks, R., Olsson, T., & Jellum, E. (2004) · International Journal of Cancer · doi:10.1002/ijc.11668 · Cited by 319
Li, L., Aggarwal, B. B., Shishodia, S., Abbruzzese, J., & Kurzrock, R. (2004) · Cancer · doi:10.1002/cncr.20605 · Cited by 289
Tumor vascularity and tryptase‐positive mast cells correlate with a poor prognosis in melanoma
Ribatti, D., Ennas, M. G., Vacca, A., Ferreli, F., Nico, B., Orru, S., & Sirigu, P. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01152.x · Cited by 262
Insulin resistance and hyperinsulinaemia in the development and progression of cancer
Godsland, I. F. (2010) · Clinical Science · doi:10.1042/cs20090399 · Cited by 231
Inhibitory effects of curcumin on tumorigenesis in mice
Huang, M.-T., Newmark, H. L., & Frenkel, K. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1997)27+<26::aid-jcb7>3.0.co;2-3 · Cited by 229
The role of diabetes mellitus in the aetiology of renal cell cancer
Lindblad, P., Chow, W. H., Chan, J., Bergström, A., Wolk, A., Gridley, G., McLaughlin, J. K., Nyrén, O., & Adami, H. O. (1999) · Diabetologia · doi:10.1007/s001250051122 · Cited by 220
Saxena, N. K., Taliaferro-Smith, L., Knight, B. B., Merlin, D., Anania, F. A., O'Regan, R. M., & Sharma, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1952 · Cited by 213
Carey, D. G., Cowin, G. J., Galloway, G. J., Jones, N. P., Richards, J. C., Biswas, N., & Doddrell, D. M. (2002) · Obesity Research · doi:10.1038/oby.2002.137 · Cited by 210
Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research
Hursting, S. D., Smith, S. M., Lashinger, L. M., Harvey, A. E., & Perkins, S. N. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp280 · Cited by 205
Self-citationDifferential effects of leptin on cancer in vitro
Somasundar, P., Yu, A. K., Vona-Davis, L., & McFadden, D. W. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00166-5 · Cited by 202
Relationship of Metabolic Risk Factors and Development of Cardiovascular Disease and Diabetes
Haffner, S. M. (2006) · Obesity · doi:10.1038/oby.2006.291 · Cited by 200
Chuang, S.-E., Cheng, A.-L., Lin, J.-K., & Kuo, M.-L. (2000) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(00)00101-0 · Cited by 199
Leptin Is Associated with Increased Prostate Cancer Risk: A Nested Case-Referent Study1
Stattin, P., Söderberg, S., Hallmans, G., Bylund, A., Kaaks, R., Stenman, U.-H., Bergh, A., & Olsson, T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7328 · Cited by 196
Inhibitory effect of dietary curcumin on skin carcinogenesis in mice
Limtrakul, P., Lipigorngoson, S., Namwong, O., Apisariyakul, A., & Dunn, F. W. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00187-0 · Cited by 194
Stark, L. A., Din, F. V. N., Zwacka, R. M., & Dunlop, M. G. (2001) · The FASEB Journal · doi:10.1096/fj.00-0529fje · Cited by 191
Chen, H., Zhang, Z., Zhang, Y.-L., & Zhou, D. (1999) · PubMed · Cited by 187
Plasma leptin and colorectal cancer risk: A prospective study in Northern Sweden
Stattin, P., Palmqvist, R., Söderberg, S., Biessy, C., Ardnor, B., Hallmans, G., Kaaks, R., & Olsson, T. (2003) · Oncology Reports · doi:10.3892/or.10.6.2015 · Cited by 178
Diabetes and Risk of Endometrial Cancer: A Population-Based Prospective Cohort Study
Friberg, E., Mantzoros, C. S., & Wolk, A. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0751 · Cited by 172
Larsson, S. C., Bergkvist, L., & Wolk, A. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.5.1171 · Cited by 166
Rouet‐Benzineb, P., Aparicio, T., Guilmeau, S., Pouzet, C., Descatoire, V., Buyse, M., & Bado, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312999200 · Cited by 164
Inflammation in obesity-related diseases
O’Rourke, R. W. (2008) · Surgery · doi:10.1016/j.surg.2008.08.038 · Cited by 161
Adipose tissue as an endocrine organ: impact on insulin resistance.
Im, J., Pijl, H., & Ae, M. (2003) · PubMed · Cited by 155
Leptin Is Associated with Increased Prostate Cancer Risk: A Nested Case-Referent Study
Stattin, P. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1341 · Cited by 142
Jaffe, T., & Schwartz, B. (2008) · International Journal of Cancer · doi:10.1002/ijc.23821 · Cited by 139
Cascinu, S., Berardi, R., Labianca, R., Siena, S., Falcone, A., Aitini, E., Barni, S., Costanzo, F. D., Dapretto, E., Tonini, G., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70383-2 · Cited by 136
Cyclooxygenase-2 In Human Pathological Disease
Koki, A. T., Khan, N., Woerner, B. M., Dannenberg, A. J., OLSON, L. M., Seibert, K., Edwards, D. A., Hardy, M. M., Isakson, P. C., & Masferrer, J. L. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0193-0_28 · Cited by 134
Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease
Hosokawa, T., Kusugami, K., Ina, K., Ando, T., Shinoda, M., Imada, A., Ohsuga, M., Sakai, T., Matsuura, T., Ito, K., et al. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01989.x · Cited by 123
Kim, D. H., Kim, J., Yu, B. P., & Chung, H. Y. (2007) · Biogerontology · doi:10.1007/s10522-007-9114-6 · Cited by 120
Foltz, C. J., Fox, J. G., Cahill, R., Murphy, J. C., Yan, L., Shames, B., & Schauer, D. B. (1998) · Helicobacter · doi:10.1046/j.1523-5378.1998.08006.x · Cited by 118
Anthropometric measures, plasma adiponectin, and breast cancer risk
Tian, Y.-F., Chu, C.-H., Wu, M.-H., Chang, C.-L., Yang, T., Chou, Y., Hsu, G., Yu, C., Yu, J., & Sun, C. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0089 · Cited by 116
Inflammation and cancer: the long reach of Ras
Karin, M. (2005) · Nature Medicine · doi:10.1038/nm0105-20 · Cited by 109
Yip-Schneider, M., Nakshatri, H., Sweeney, C. J., Marshall, M. S., Wiebke, E. A., & Schmidt, C. M. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0215 · Cited by 106
Fenton, J. I., Hursting, S. D., Perkins, S. N., & Hord, N. G. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl018 · Cited by 102
Self-citationAdiponectin and adiponectin receptor in relation to colorectal cancer progression
Byeon, J., Jeong, J., Kim, M. J., Lee, S., Nam, W., Myung, S., Kim, J. G., Yang, S., Kim, J., & Suh, D. J. (2010) · International Journal of Cancer · doi:10.1002/ijc.25301 · Cited by 96
Colby, J. K., Klein, R. D., McArthur, M. J., Conti, C. J., Kiguchi, K., Kawamoto, T., Riggs, P. K., Pavone, A., Sawicki, J. A., & Fischer, S. M. (2008) · Neoplasia · doi:10.1593/neo.08330 · Cited by 88
Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines
El-Rayes, B. F., Ali, S. S., Sarkar, F. H., & Philip, P. A. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1421.3.11 · Cited by 87
Kim, T. H., Choi, S., Ha, E. S., Jung, J. G., Han, S. J., Kim, H. J., Kim, D. J., KANG, Y. Y., & Lee, K. W. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0259-z · Cited by 84
Leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms
Somasundar, P. S., Riggs, D. R., Jackson, B., Vona-Davis, L. C., & McFadden, D. W. (2003) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2003.07.017 · Cited by 68
Pandelidou, M., DIMAS, K. S., Georgopoulos, A., Hatziantoniou, S., & Demetzos, C. (2011) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2011.3093 · Cited by 59
Inhibition of inflammatory response in transgenic fat-1 mice on a calorie-restricted diet
Bhattacharya, A., Chandrasekar, B., Rahman, M. M., Banu, J., Kang, J. X., & Fernandes, G. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.093 · Cited by 57
Premalignant breast lesions: role for biological markers in predicting progression to cancer
Stoll, B. A. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00026-x · Cited by 47
Cited by
Metabolic Syndrome and Risk of Cancer
Esposito, K., Chiodini, P., Colao, A., Lenzi, A., & Giugliano, D. (2012) · Diabetes Care · doi:10.2337/dc12-0336 · Cited by 1,209
Matsuda, M., & Shimomura, I. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2013.05.004 · Cited by 641
Obesity and cancer risk: evidence, mechanisms, and recommendations
Vucenik, I., & Stains, J. P. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06750.x · Cited by 571
Nutrients and Oxidative Stress: Friend or Foe?
Tan, B. L., Norhaizan, M. E., & Liew, W.-P.-P. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9719584 · Cited by 403
Adipose tissue, obesity and adipokines: role in cancer promotion
Booth, A., Magnuson, A., Fouts, J., & Foster, M. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0037 · Cited by 329
Metadata
- Authors
- Harvey, A. E., Lashinger, L. M., & Hursting, S. D.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2011-07
- Volume
- 1229
- Issue
- 1
- Pages
- 45-52
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2110160985
- Cited by
- 272
- References
- 90
- FWCI
- 18.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.